000 06251cam a2200493 i 4500
001 on1096211884
003 OCoLC
005 20230525144726.0
006 m o d
007 cr |n|||||||||
008 190409t20202020paua ob 000 0 eng d
020 _a9780323609876
_qebook
029 1 _aAU@
_b000065479670
035 _a(OCoLC)1096211884
_z(OCoLC)1099201272
_z(OCoLC)1103164343
037 _3Book
040 _aMMU
_beng
_erda
_epn
_cMMU
_dTMC
_dOCLCO
_dUSU
_dUAB
_dOPELS
_dCASUM
_dOCLCO
_dUIU
_dOCLCO
_dOPELS
_dYDX
_dRDF
_dOCLCO
_dOCLCA
_dOCLCQ
_dOPELS
_dOCLCO
_dCOM
049 _aMAIN
050 4 _aRC681
060 4 _aWG 370
_bH43618 2016
082 0 4 _a616.12
_223
130 0 _aHeart failure (Mann)
245 1 0 _aHeart failure :
_ba companion to Braunwald's heart disease /
_c[edited by] G. Michael Felker, Douglas L. Mann.
264 1 _aPhiladelphia, PA :
_bElsevier,
_c2020
264 4 _c©2020
300 _axx, 718 pages
_billustrations (chiefly color)
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
504 _aIncludes bibliographical references.
505 0 _aMolecular basis of heart failure -- Cellular basis for heart failure -- Cellular basis for myocardial regeneration and repair -- Myocardial basis for heart failure : role of cardiac interstitium -- Molecular signaling mechanisms of the renin-angiotensin system in heart failure -- Adrenergic receptor signaling in heart failure -- Role of innate immunity in heart failure -- Oxidative stress in heart failure -- Natriuretic peptides in heart failure: pathophysiologic and therapeutic implications -- Systolic dysfunction in heart failure -- Alterations in ventricular function : diastolic heart failure -- Alterations in ventricular structure : role of left ventricular remodeling and reverse remodeling in heart failure -- Alterations in the sympathetic and parasympathetic nervous systems in heart failure -- Alterations in the peripheral circulation in heart failure -- Alterations in kidney function associated with heart failure -- Alterations in skeletal muscle in heart failure -- Alterations in cardiac metabolism in heart failure -- Epidemiology of heart failure -- Heart failure as a consequence of ischemic heart disease -- Heart failure as a consequence of dilated cardiomyopathy -- Restrictive and infiltrative cardiomyopathies and arrhythmogenic right ventricular dysplasia/cardiomyopathy -- Cardiac amyloidosis -- Heart failure as a consequence of hypertrophic cardiomyopathy -- Heart failure as a consequence of genetic cardiomyopathy -- Heart failure as a consequence of hypertension -- Heart failure as a consequence of valvular heart disease -- Heart failure as a consequence of congenital heart disease -- Heart failure as a consequence of viral and nonviral myocarditis -- Heart failure in the developing world -- Heart failure and human immunodeficiency virus -- Clinical evaluation of heart failure -- Cardiac imaging in heart failure -- Biomarkers and precision medicine in heart failure -- Hemodynamics in heart failure -- Disease prevention in heart failure -- Acute heart failure -- Contemporary medical therapy for heart failure patients with reduced ejection fraction -- Management of arrhythmias and device therapy in heart failure -- Treatment of heart failure with preserved ejection fraction -- Management of heart failure in special populations : older patients, women, and racial/ethnic minority groups -- Stem cell-based and gene therapies in heart failure -- Neuromodulation in heart failure -- Pulmonary hypertension -- Heart transplantation -- Circulatory assist devices in heart failure -- Cardio-oncology and heart failure -- Disease management and telemedicine in heart failure -- Management of comorbidities in heart failure -- Quality and outcomes in heart failure -- Decision making and palliative care in advanced heart failure
520 _aUp-to-date, authoritative and comprehensive, Heart Failure, 4th Edition, provides the clinically relevant information you need to effectively manage and treat patients with this complex cardiovascular problem. This fully revised companion to Braunwald's Heart Disease helps you make the most of new drug therapies such as angiotensin receptor neprilysin inhibitors (ARNIs), recently improved implantable devices, and innovative patient management strategies. Led by internationally recognized heart failure experts Dr. G. Michael Felker and Dr. Douglas Mann, this outstanding reference gives health care providers the knowledge to improve clinical outcomes in heart failure patients. Focuses on a clinical approach to treating heart failure, resulting from a broad variety of cardiovascular problems. Covers the most recent guidelines and protocols, including significant new updates to ACC, AHA, and HFSA guidelines. Covers key topics such as biomarkers and precision medicine in heart failure and new data on angiotensin receptor neprilysin inhibitors (ARNIs). Contains four new chapters: Natriuretic Peptides in Heart Failure; Amyloidosis as a Cause of Heart Failure; HIV and Heart Failure; and Neuromodulation in Heart Failure. Covers the pathophysiological basis for the development and progression of heart failure. Serves as a definitive resource to prepare for the ABIM's Heart Failure board exam. 2016 British Medical Association Award: First Prize, Cardiology (3rd Edition). Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.
590 _aElsevier
650 0 _aHeart failure.
_0http://id.loc.gov/authorities/subjects/sh85059745
650 1 2 _aHeart Failure
655 0 _aElectronic books.
_bNATCOLCK
655 4 _aElectronic books.
_bNATCOLCK
700 1 _aFelker, G. Michael,
_eeditor.
700 1 _aMann, Douglas L.,
_eeditor.
730 0 _iComplemented by (expression):
_aBraunwald's heart disease.
_sEleventh edition.
776 0 8 _iPrint version:
_tHeart failure.
_bFourth edition.
_dPhiladelphia, PA : Elsevier, [2020]
_z9780323609876
_w(OCoLC)1088903426
942 _c4WK
_n0
_2ddc
999 _c129731
_d129731